Is GE HealthCare Technologies Inc. (GEHC) overvalued? · P/E 15, rev $20.63B
GE HealthCare Technologies Inc. (GEHC) is a medical devices company listed on NASDAQ.
This page asks whether GE HealthCare Technologies Inc. (GEHC) looks expensive on cached numbers — not a short thesis.
Latest reported GEHC revenue for 2025-12-31 was $20.63B. Net income was $2.08B. Revenue was up 4.8% from 2024-12-31 to 2025-12-31. GEHC currently screens at market cap $27.82B and trailing P/E 14.7.
GEHC currently screens at market cap $27.82B and trailing P/E 14.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GEHC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GEHC stock page for the full model, not this heading.
Not investment advice.